Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-09 Sale | 2023-08-11 4:25 pm | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 8 | $3.395 | $27 | 37,010 (Indirect Direct) | View |
| 2021-06-03 Purchase | 2021-06-07 5:36 pm | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 96,153 | $3.12 | $299,997 | 43,077 (Indirect Direct) | View |
| 2021-06-03 Purchase | 2021-06-07 5:25 pm | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer | 823,170 | $3.28 | $2,699,998 | 2,049,153 (Indirect Direct) | View |
| 2021-06-03 Purchase | 2021-06-07 4:05 pm | Cyclerion Therapeutics Inc. | CYCN | Slate Path Capital LP Greenspan David Gerald 10% Owner | 961,538 | $3.12 | $2,999,999 | 7,157,601 (Indirect) | View |
| 2021-05-06 Purchase | 2021-05-10 08:45 am | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer | 302,000 | $2.43 | $733,860 | 1,225,983 (Indirect Direct) | View |
| 2021-05-04 Purchase | 2021-05-06 9:27 pm | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer | 698,001 | $2.4268 | $1,693,943 | 923,983 (Indirect Direct) | View |
| 2021-02-25 Sale | 2021-03-01 4:23 pm | Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer | 1,824 | $4 | $7,296 | 31,599 (Direct) | View |
| 2021-02-25 Sale | 2021-03-01 4:17 pm | Cyclerion Therapeutics Inc. | CYCN | Wright Christopher I Chief Medical Officer | 2,637 | $3.99 | $10,522 | 42,728 (Direct) | View |
| 2020-12-28 Sale | 2020-12-30 1:14 pm | Cyclerion Therapeutics Inc. | CYCN | Currie Mark G President and CSO | 20,107 | $3.01 | $60,522 | 251,648 (Direct) | View |
| 2020-11-09 Purchase | 2020-11-12 5:05 pm | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer | 125,000 | $2.53 | $316,250 | 254,704 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-19 Option Award | 2023-05-22 8:43 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer 10% Owner | 576,037 | $8.68 | 678,494 (Direct) | View |
| 2022-07-25 Option Award(A) | 2022-07-27 4:40 pm | N/A 2032-07-25 | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 57,753 | $0 | 57,753 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-26 4:33 pm | N/A 2032-07-25 | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 57,753 | $0 | 57,753 (Direct) | View |
Ownership | 2022-07-26 4:30 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 0 | $0 | 0 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | CONRADES GEORGE H Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:55 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Isacson Ole Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 8:55 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 11:48 am | N/A 2032-01-20 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 11:43 am | N/A 2032-01-20 | Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-24 11:38 am | N/A 2032-01-03 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer | 482,950 | $0 | 482,950 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 11:33 am | N/A 2032-01-20 | Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-10 4:32 pm | N/A 2031-12-09 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-10 4:31 pm | N/A 2031-12-09 | Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-10 4:31 pm | N/A 2031-12-09 | Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:27 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:25 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:22 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Isacson Ole Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:17 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Churchwell Kevin Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:14 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:11 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | CONRADES GEORGE H Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:08 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 5:05 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2021-05-19 6:16 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2021-01-11 5:49 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer | 0 | $0 | 232,006 (Direct) | View |
Ownership | 2021-01-11 5:45 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer | 0 | $0 | 357,014 (Direct) | View |
Ownership | 2020-12-30 9:53 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Wright Christopher I Chief Medical Officer | 0 | $0 | 414,645 (Direct) | View |